5 completed, 2 not yet recruiting, 2 recruiting. 5 Phase 2, 4 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Not yet recruiting 2, Recruiting 2, Completed 1 |
| Not applicable | 4 | Completed 4 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow 2-HOBA: new trials by email Literature Review of 2-HOBA trials Research Report on 2-HOBA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension 2-HOBA - Pulmonary Arterial Hypertension | Phase 2 | Not yet recruiting | Vanderbilt University Medical Center | 12 | 2027-05-01 | 2026-11-10 |
| 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients 2-hydroxybenzylamine acetate, Placebo - Alzheimer Disease, Mild Cognitive Impairment | Phase 1 / Phase 2 | Not yet recruiting | MTI Biotech Inc | 48 | 2026-09-01 | 2026-09-24 |
| 2-HOBA in Systemic Lupus Erythematosus 2-HOBA acetate (2-Hydroxybenzlamine acetate), Placebo - Systemic Lupus Erthematosus (SLE) | Phase 2 | Recruiting | Vanderbilt University Medical Center | 42 | 2026-05-15 | 2026-05-22 |
| 2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH) 2-Hydroxybenzylamine, Placebo - Familial Hypercholesterolemia | Phase 2 | Recruiting | Vanderbilt University Medical Center | 72 | 2024-02-14 | 2026-08-07 |
| 2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis 2-HOBA, Placebo - Rheumatoid Arthritis | Phase 2 | Completed | Vanderbilt University Medical Center | 32 | 2022-08-09 | 2026-04-08 |
| 2-HOBA: Multiple Dosing Study in Older Adults 2-HOBA, Placebo - Older Adults | Not applicable | Completed | Metabolic Technologies Inc. | 18 | 2018-05-23 | 2021-12-14 |
| 2-HOBA: Multiple Dosing Study in Healthy Humans 2-HOBA, Placebo - Healthy Volunteers | Not applicable | Completed | Metabolic Technologies Inc. | 18 | 2018-05-23 | 2019-08-13 |
| Brain Penetrance of 2-HOBA in Humans 2-HOBA - Healthy Adults | Not applicable | Completed | Metabolic Technologies Inc. | 3 | 2018-05-23 | 2019-02-20 |
| 2-HOBA: Initial Evaluation in Humans 2-HOBA - Healthy Volunteers | Not applicable | Completed | Metabolic Technologies Inc. | 18 | 2017-08-02 | 2018-06-04 |
Alzheimer Disease (1) · Arthritis, Rheumatoid (1) · Cognitive Dysfunction (1) · Hyperlipoproteinemia Type II (1) · Hypertension (1) · Hypertension, Pulmonary (1) · Lupus Erythematosus, Systemic (1) · Pulmonary Arterial Hypertension (1)
Metabolic Technologies Inc. (4) · Vanderbilt University Medical Center (4) · MTI Biotech Inc (1)
United States (8)
John A Rathmacher, PhD (4) · John A. Rathmacher, Ph.D. (1) · MacRae F. Linton, MD (1) · Michelle J Ormseth, MD, MSCI (1) · Michelle Ormseth, MD, MSCI (1) · Patricia Andrews, M.D. (1) · Paul A. Newhouse, M.D. (1)
R44AG055184 (4), P01HL116263 (1), P01HL174442 (1)